ArticleJournal of gastrointestinal cancer2025
Does Omitting Additional Surgery After Local Resection Affect Oncological Outcomes in Patients with High-Risk pT1 Colorectal Cancer?
Article in Journal of gastrointestinal cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionColorectal cancer (CRC) is a leading cause of cancer-related mortality in Spain, with pT1 adenocarcinomas often managed via endoscopic polypectomy (EP). Determining the necessity of additional surgery post-EP remains challenging, especially given the low incidence of intramural residual tumor (IRT) and lymph node metastasis (LNM) in certain high-risk cases. This study aims to evaluate histological factors predicting residual disease and to explore strategies to reduce unnecessary completion surgeries.
methodsWe analyzed data from 276 patients with pT1 CRC arising from colonic and upper rectal polyps treated with complete EP at our institution between 2013 and 2021. pT1-polyps with positive resection margins, deep submucosal invasion ≥ 2 mm, presence of lymphovascular invasion, high-grade tumor budding, unfavorable histology, or indeterminate polyps were considered high-risk pT1-polyps. Patients were stratified into low-risk (LR), high-risk endoscopic management (HR-E), and high-risk surgical management (HR-S) groups. Follow-up involved clinical, endoscopic, and imaging surveillance over a median of 70 months. IRT, LNM, recurrence, and survival outcomes were analyzed.
resultsOf the 276 patients, 88 (32%) were low-risk managed endoscopically, while 188 (68%) exhibited high-risk features; 128 underwent surgery (HR-S), and 60 were managed with surveillance (HR-E). Residual disease was identified in 18.7% of surgical specimens. IRT was predominantly associated with positive margins (p = 0.01). Unfavorable histology was strongly linked to LNM (p = 0.000). Recurrence rates were similar between HR-E and HR-S groups in patients with a single risk factor, with local recurrences effectively managed surgically. No CRC-specific deaths occurred in the HR-E group, and overall survival was better among patients with lower ASA scores and favorable histology.
conclusionPositive resection margins and unfavorable histology are significant predictors of IRT and LNM in pT1 CRC. Careful patient selection and vigilant follow-up may allow safe deferral of completion surgery in selected high-risk patients, especially those with comorbidities or a single histological risk factor, thereby reducing surgical morbidity without compromising survival.
Indexed as
Identifiers
40836179What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.